Jasti Property and Equity Holdings Private Limited, acting as the sole trustee for the Jasti Family Trust, has disclosed a change in shareholding in Cohance Lifesciences Limited, effective February 18, 2026. The filing under Regulation 29(2) details the sale of 78,76,948 shares, equivalent to 2.06% of the total voting capital. Following the transaction, the aggregate shareholding of the group stands at 6.36% of the total voting capital.
Disclosure of Shareholding Change
A mandatory disclosure has been filed concerning a change in shareholding in Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) by Jasti Property and Equity Holdings Private Limited, acting as the sole Trustee of the Jasti Family Trust, along with Persons Acting in Concert (PACs).
The transaction date for the acquisition/sale was reported as February 18, 2026. The mode of disposal was via Open market and Inter-se transfer through Block Deals.
Pre- and Post-Transaction Holdings
The filing details the aggregate holdings of the acquirer group before and after the disposal. The total holding before the transaction, calculated across shares, warrants, and voting rights, stood at 2,52,02,957 shares, representing 6.59% of the total voting capital.
The transaction involved the sale or disposal of 78,76,948 shares carrying voting rights, which equates to 2.06% of the total share/voting capital applicable.
Post-Sale Consolidated Holding:
- Total shares carrying voting rights held by the group post-transaction: 2,43,26,009 shares.
- This represents 6.36% of the total voting capital.
- The details confirm that the holding of Jasti Property and Equity Holdings Private Limited (on behalf of the Trust) reduced from 2,51,92,957 shares (6.59%) to 1,73,16,009 shares (4.53%).
Capital Structure Details
The equity share capital/total voting capital of the Target Company before and after the sale remained constant at 38,25,67,140 equity shares.
However, the total diluted share/voting capital of the TC after the said transaction is noted as 39,22,07,995 shares.
It is noted that out of the 78,76,948 shares sold, 8,76,948 shares (0.23% of total equity of the TC) were sold in the open market between 08-09-2025 and 08-01-2026.
Source: BSE
